Myosin5B, a Prognostic and Predictive Marker for CRC Patients
Gene signature for the prediction of recurrence and response to chemotherapy in early stage colorectal cancer patient
Published: 25th March 2020

Patents
- WO 2019/034549 Novel Biomarkers For Cancer Diagnosis, Prediction Or Staging
IP Status
- Patent application submitted
Seeking
- Licensing
- Commercial partner
- Development partner